SARS2 and Middle East respiratory syndrome: Notably, Middle East respiratory syndrome (MERS) has a leucine at the equivalent position in Mpro (Fig. 2A), and it exhibits higher ensitrelvir antiviral median effective concentration (EC50) values compared to SARS and SARS2 (14).